Country: European Union
Language: English
Source: EMA (European Medicines Agency)
ivabradine hydrochloride
Accord Healthcare S.L.U.
C01EB17
ivabradine
Cardiac therapy
Angina Pectoris; Heart Failure
Symptomatic treatment of chronic stable angina pectorisIvabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm.Ivabradine is indicated :- in adults unable to tolerate or with a contra-indication to the use of beta-blockers- or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.Treatment of chronic heart failureIvabradine is indicated in chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated. (see section 5.1)
Revision: 6
Authorised
2017-05-22
30 B. PACKAGE LEAFLET 31 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT IVABRADINE ACCORD 5 MG FILM-COATED TABLETS IVABRADINE ACCORD 7.5 MG FILM-COATED TABLETS ivabradine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Ivabradine Accord is and what it is used for 2. What you need to know before you take Ivabradine Accord 3. How to take Ivabradine Accord 4. Possible side effects 5 How to store Ivabradine Accord 6. Contents of the pack and other information 1. WHAT IVABRADINE ACCORD IS AND WHAT IT IS USED FOR Ivabradine Accord is a heart medicine used to treat: - Symptomatic stable angina pectoris (which causes chest pain) in adult patients whose heart rate is over or equal to 70 beats per minute. It is used in adult patients who do not tolerate or cannot take heart medicines called beta-blockers. It is also used in combination with beta-blockers in adult patients whose condition is not fully controlled with a beta-blocker. - Chronic heart failure in adult patients whose heart rate is over or equal to 75 beats per minute. It is used in combination with standard therapy, including beta-blocker therapy or when beta-blockers are contraindicated or not tolerated. About stable angina pectoris (usually referred to as “angina”): Stable angina is a heart disease which happens when the heart does not receive enough oxygenThe most common symptom of angina is chest pain or discomfort. About chronic heart failure: Chronic heart failure is a heart disease which happens when your heart cannot pump enough bloo Read the complete document
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Ivabradine Accord 5 mg film-coated tablets Ivabradine Accord 7.5 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _ _ Ivabradine Accord 5 mg film-coated tablets Each film-coated tablet contains 5 mg ivabradine (as hydrochloride). _Excipient with known effect _ Each 5 mg film-coated tablet contains 72 mg lactose (as anhydrous). Ivabradine Accord 7.5 mg film-coated tablets Each film-coated tablet contains 7.5 mg ivabradine (as hydrochloride). _Excipient with known effect _ Each 7.5 mg film-coated tablet contains 108 mg lactose (as anhydrous). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Ivabradine Accord 5 mg film-coated tablets Salmon-coloured, oblong shaped, approximately 8.50 mm in length, 4.50 mm in width, film-coated tablets scored on both sides, debossed with “FK” on one side and “2” on other side. The tablet can be divided into equal doses. Ivabradine Accord 7.5 mg film-coated tablets Salmon-coloured, triangular shaped, approximately 7.30 mm in length, 6.80 mm in width, film-coated tablets debossed with “FK” on one side and “1” on other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of chronic stable angina pectoris Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. Ivabradine is indicated: - in adults unable to tolerate or with a contraindication to the use of beta-blockers - or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose. 3 Treatment of chronic heart failure Ivabradine is indicated in chronic heart failure New York Heart Association (NYHA) II to IV class with systolic dysfunction, in adult patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker Read the complete document